Charles Bisgaier
Chief Executive Officer chez BioSavita, Inc.
Profil
Charles L.
Bisgaier was the founder of Esperion Therapeutics, Inc. (founded in 1998) where he held the title of Vice President from 1998 to 2004.
He was also the founder of Gemphire Therapeutics, Inc. (founded in 2014) where he served as Chairman & Chief Scientific Officer from 2014 to 2019.
Additionally, he founded Michigan Life Therapeutics in 2008 and held the position of Chief Executive Manager from 2008 to 2014.
He also founded Michigan Life Ventures in 2008 and served as Chief Executive Manager.
Currently, Dr. Bisgaier is the Chairman & Chief Executive Officer at BioSavita, Inc. and a Director at Hygieia, Inc. In the past, Dr. Bisgaier worked as a Director at Sierra Oncology, Inc. from 2010 to 2014.
He was also a Senior Director-Pharmacology at Pfizer (St. Louis) from 2004 to 2006.
He served as President at Pipex Therapeutics, Inc. from 2006 to 2008 and as President & Secretary at Theriva Biologics, Inc. from 2006 to 2008.
He also held the position of Chief Scientific Officer at NeuroBo Pharmaceuticals, Inc.Dr. Bisgaier completed his graduate degree in 1977 and his doctorate degree in 1981 from George Washington University.
He also obtained his undergraduate degree in 1974 from State University of New York College at Oneonta.
Postes actifs de Charles Bisgaier
| Sociétés | Poste | Début |
|---|---|---|
Hygieia, Inc.
 Hygieia, Inc. Industrial MachineryProducer Manufacturing Hygieia, Inc. engages in the provision of healthcare services focusing on insulin management. It offers the d-Nav Insulin Management Program. The company was founded by Israel Hodish and Eran Bashan in 2008 and is headquartered in Livonia, MI. | Director/Board Member | - |
BioSavita, Inc.
 BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Chief Executive Officer | - |
Anciens postes connus de Charles Bisgaier
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Founder | 30/12/2019 |
| Michigan Life Therapeutics | Founder | 01/11/2014 |
| SIERRA ONCOLOGY, INC. | President | 12/11/2012 |
| THERIVA BIOLOGICS, INC. | President | 01/07/2008 |
Pipex Therapeutics, Inc.
 Pipex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pipex Therapeutics, Inc. develops drugs for the treatment of neurologic and fibrotic diseases. The firm has three subsidiaries, Effective Pharmaceuticals, Inc., CD4 Biosciences, Inc. and Solovax, Inc. It is located in Ann Arbor, MI. | President | - |
Formation de Charles Bisgaier
| George Washington University | Graduate Degree |
| State University of New York College at Oneonta | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| THERIVA BIOLOGICS, INC. | Health Technology |
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Hygieia, Inc.
Hygieia, Inc. Industrial MachineryProducer Manufacturing Hygieia, Inc. engages in the provision of healthcare services focusing on insulin management. It offers the d-Nav Insulin Management Program. The company was founded by Israel Hodish and Eran Bashan in 2008 and is headquartered in Livonia, MI. | Producer Manufacturing |
Pipex Therapeutics, Inc.
Pipex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pipex Therapeutics, Inc. develops drugs for the treatment of neurologic and fibrotic diseases. The firm has three subsidiaries, Effective Pharmaceuticals, Inc., CD4 Biosciences, Inc. and Solovax, Inc. It is located in Ann Arbor, MI. | Health Technology |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a private company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
BioSavita, Inc.
BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Health Technology |
| Michigan Life Therapeutics | |
| Michigan Life Ventures |
